Sun Yiwei, Yao Xiaxi, Zhang Yiqun, Zhang Wei, Zhu Can, Shen Cailiang, Wang Yuanyin, Wang Xianwen
Department of Orthopedics, The First Affiliated Hospital of Anhui Medical University, Hefei 230022, P. R. China.
College and Hospital of Stomatology, Anhui Medical University, Key Lab. of Oral Diseases Research of Anhui Province, Hefei 230032, P. R. China.
ACS Appl Mater Interfaces. 2025 May 21;17(20):29100-29118. doi: 10.1021/acsami.4c23069. Epub 2025 Apr 17.
Bone defects caused by trauma, tumors, or infections pose significant challenges to clinical treatment because of the complex pathological microenvironment they create. Elevated levels of inflammatory factors and reactive oxygen species (ROS) at the defect site disrupt the bone immune microenvironment, impeding bone regeneration. Concurrently, the vascular damage frequently associated with bone defects leads to hypoxia, further complicating therapeutic efforts. Although bone grafting remains a primary clinical approach, its efficacy is limited by these adverse conditions. In this study, a ZnO-CuS/F127 nanozyme hydrogel with multiple enzymatic activities was manufactured for bone defect repair via the modulation of the bone immune microenvironment and the promotion of osteo-/angiogenesis, which was accomplished via the encapsulation of ZnO-CuS nanoflowers synthesized via calcination into the F127 hydrogel matrix. ZnO-CuS bimetallic nanoenzymes exhibit robust catalase (CAT) and superoxide dismutase-like activities, enabling effective scavenging of diverse ROS species . In cellular assays, ZnO-CuS/F127 protected bone marrow mesenchymal stem cells [bone mesenchymal stem cells (BMSCs)] from ROS-induced cytotoxicity and promoted macrophage polarization toward the anti-inflammatory M2 phenotype, thus modulating the bone immune microenvironment. The ZnO-CuS/F127 hydrogel demonstrated potent proangiogenic and pro-osteogenic effects, attributed to its ability to upregulate the Wnt/β-catenin signaling pathway while inhibiting the NF-κB pathway in BMSCs, as confirmed by RNA sequencing. , the hydrogel exhibited exceptional hemostatic performance and facilitated bone defect repair in mouse hemorrhage and rat bone defect models while maintaining high biocompatibility and low cytotoxicity. This study highlights the use of the ZnO-CuS/F127 nanozyme hydrogel as a promising therapeutic strategy for bone defect repair. By modulating the immune microenvironment and promoting angiogenesis and osteogenesis, this multifunctional hydrogel offers innovative insights and a potential clinical solution for addressing the multifaceted challenges of bone regeneration.
由创伤、肿瘤或感染引起的骨缺损对临床治疗构成重大挑战,因为它们会形成复杂的病理微环境。缺损部位炎症因子和活性氧(ROS)水平升高会破坏骨免疫微环境,阻碍骨再生。同时,与骨缺损常相关的血管损伤会导致缺氧,使治疗工作更加复杂。尽管骨移植仍然是主要的临床方法,但其疗效受到这些不利条件的限制。在本研究中,通过调节骨免疫微环境和促进骨生成/血管生成,制备了一种具有多种酶活性的ZnO-CuS/F127纳米酶水凝胶用于骨缺损修复,这是通过将煅烧合成的ZnO-CuS纳米花封装到F127水凝胶基质中实现的。ZnO-CuS双金属纳米酶表现出强大的过氧化氢酶(CAT)和超氧化物歧化酶样活性,能够有效清除多种ROS。在细胞实验中,ZnO-CuS/F127保护骨髓间充质干细胞[骨间充质干细胞(BMSCs)]免受ROS诱导的细胞毒性,并促进巨噬细胞向抗炎M2表型极化,从而调节骨免疫微环境。RNA测序证实,ZnO-CuS/F127水凝胶表现出强大的促血管生成和成骨作用,这归因于其上调BMSCs中Wnt/β-连环蛋白信号通路同时抑制NF-κB通路的能力。此外,该水凝胶在小鼠出血和大鼠骨缺损模型中表现出优异的止血性能并促进骨缺损修复,同时保持高生物相容性和低细胞毒性。本研究强调了ZnO-CuS/F127纳米酶水凝胶作为一种有前景的骨缺损修复治疗策略的应用。通过调节免疫微环境以及促进血管生成和成骨,这种多功能水凝胶为应对骨再生的多方面挑战提供了创新见解和潜在的临床解决方案。